Author: Marlo Holden

  • Kaz Minerals Plunges After Agreeing to Buy $5.5-Billion-Outlay Russia Copper Project

    Shares of Kaz Minerals (KAZ.L), a company focused on large-scale, low-cost copper mining, slumped early Thursday, after the company said it was buying the Baimskaya copper project in the Chukotka region of Russia for $900 million, taking on a project with a gigantic capital budget outlay of $5.5 billion. The miner, whose board approved in December 2017 a $1.2 billion […]

    Read More
  • United Therapeutics’ Price Target From Wedbush Boosted to $253

    United Therapeutics (UTHR) received a price-target increase late Wednesday from Wedbush after the biotechnology company reported Q2 results well above analysts’ expectations earlier in the day. The new price target on the stock from Wedbush is $253 per share, up from $234. The shares closed Wednesday at $116.66 and edged down 0.6% after hours to $116.00. Wedbush kept its investment […]

    Read More